Allurion Technologies Inc.
General ticker "ALUR" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $120.9M (TTM average)
Allurion Technologies Inc. does not follow the US Stock Market performance with the rate: -9.8%.
Estimated limits based on current volatility of 4.6%: low 1.37$, high 1.50$
Factors to consider:
- Total employees count: 252 as of 2023
- Current price 77.7% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [6.58$, 21.29$]
- 2025-12-31 to 2026-12-31 estimated range: [6.95$, 20.42$]
Financial Metrics affecting the ALUR estimates:
- Negative: with PPE of -1.3 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -197.68 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: Shareholder equity ratio, % of -237.64 <= 18.93
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
Short-term ALUR quotes
Long-term ALUR plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $64.21MM | $53.47MM | $32.11MM |
| Operating Expenses | $96.22MM | $132.54MM | $82.31MM |
| Operating Income | $-32.01MM | $-79.08MM | $-50.20MM |
| Non-Operating Income | $-5.59MM | $-1.26MM | $24.77MM |
| Interest Expense | $4.43MM | $10.57MM | $2.26MM |
| R&D Expense | $16.97MM | $27.69MM | $17.37MM |
| Income(Loss) | $-37.60MM | $-80.34MM | $-25.43MM |
| Taxes | $0.14MM | $0.26MM | $0.72MM |
| Profit(Loss)* | $-37.74MM | $-80.61MM | $-26.15MM |
| Stockholders Equity | $-32.31MM | $-70.49MM | $-77.98MM |
| Inventory | $3.87MM | $6.17MM | $3.40MM |
| Assets | $51.37MM | $71.71MM | $32.81MM |
| Operating Cash Flow | $-46.98MM | $-63.98MM | $-42.30MM |
| Capital expenditure | $1.55MM | $1.61MM | $0.61MM |
| Investing Cash Flow | $-1.55MM | $-1.61MM | $-0.61MM |
| Financing Cash Flow | $30.54MM | $95.99MM | $20.21MM |
| Earnings Per Share** | $-37.75 | $-57.83 | $-11.64 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.